Literature DB >> 32677561

Implant Retention or Removal for Management of Surgical Site Infection After Spinal Surgery.

Aakash Agarwal1, Amey Kelkar1, Ashish G Agarwal2, Daksh Jayaswal1, Christian Schultz1, Arvind Jayaswal2, Vijay K Goel1, Anand K Agarwal1, Sandeep Gidvani3.   

Abstract

STUDY
DESIGN: A literature review.
OBJECTIVE: To summarize the implant removal rate, common bacterial organisms found, time of onset, ratio of superficial to deep infection, and regurgitating the prevalence among all the retrospective and prospective studies on management and characterization of surgical site infections (SSIs).
METHODS: PubMed was searched for articles published between 2000 and 2018 on the management or characterization of SSIs after spinal surgery. Only prospective and retrospective studies were included.
RESULTS: A total of 49 articles were found relevant to the objective. These studies highlighted the importance of implant removal to avoid recurrence of SSI. The common organisms detected were methicillin-resistant Staphylococcus aureus, methicillin-resistant Staphylococcus epidermis, Staphylococcus epidermis, Staphylococcus aureus, and Propionibacterium acnes, with prevalence of 1% to 15%. A major proportion of all were deep SSI, with minority reporting on late-onset SSI.
CONCLUSION: Long-term antibiotics administration, and continuous irrigation and debridement were common suggestion among the authors; however, the key measure undertaken or implied by most authors to avoid risk of recurrence was removal or replacement of implants for late-onset SSI.

Entities:  

Keywords:  biofilm; contamination; implant removal; implant retention; readmission; revision surgery; surgical site infection

Year:  2019        PMID: 32677561      PMCID: PMC7359681          DOI: 10.1177/2192568219869330

Source DB:  PubMed          Journal:  Global Spine J        ISSN: 2192-5682


Introduction

Surgical site infections (SSIs) are extremely burdensome to the patients, a leading cause of morbidity, and a major cause of readmission with longer lengths of stay after spinal surgery.[1] Although meticulous prophylactic surgical practice is crucial to avoid such incidences, there is always some incidence of infection in or around the area that has been instrumented in surgery.[1,2] Many authors have summarized the key prevention and postsurgical management techniques for SSI in spine surgery; however, because of the varied nature of surgical practices and the numerous factors involved, the focus has been on overall preventative and management measures.[2-4] In addition, SSIs in medical care are deemed as “never events” and their occurrence is considered to be influenced by the hospital policies and procedures. Such an outlook toward infection leads many practitioners and hospital system to bundle as many potential measures and/or increase the intensity (dosage in some cases) of individual measures, some to the point of redundancy.[5,6] The result of such practices is no less than controversial as can be exemplified simply by the previously cited ranges in prevalence of SSI.[7] Therefore, it is very useful to consistently evaluate the results of all recently published clinical practice, in an attempt to corroborate or nullify isolated variables into being effective or not. Few such variables during management of SSI are implant removal rate, common bacterial organisms found, time of onset, ratio of superficial to deep infection, and so on. Thus, the objective of this literature review is to summarize the findings on implant removal rate, common bacterial organisms found, time of onset, ratio of superficial to deep infection, and regurgitating the prevalence among all the retrospective and prospective studies on management and/or characterization of SSI.

Methods

The general method utilized for the literature review was adopted from Cochrane collaboration. Table 1 shows the search strategy that was developed for the PubMed database, for the period 2000-2018. Title and abstracts were reviewed to shortlist articles for full length review. The shortlisting was followed by full-text review of all references that appeared to retrospectively or prospectively address the key SSI management techniques at an event of surgical site infection.
Table 1.

Medline Search Strategy Using PubMed.

http://www.ncbi.nlm.nih.gov/pubmed/advanced
MeSh terms: 1. Surgical Wound Infection/surgery [mh][mh] denotes a Medical Subject Heading (MeSH) term (“exploded”);
AND (Boolean operator)
Terms for area of interest: 1. Spine [tw] 2. Spinal [tw][tw] denotes text word;
NOT (Boolean operator)
Terms for exclusion: 1. Cord [ti] 2. Case Reports [ptyp][ti] denotes title;[ptyp] denotes publication type;
AND (Boolean operator)
Terms for date range: 1. “2000/01/01”[PDat]: “2018/12/31”[PDat][PDat] denotes publication date;
Medline Search Strategy Using PubMed.

Results

A total of 79 full-text articles were retrieved after screening through titles and abstracts. Of these, only 49 articles were found relevant, and were used for the synthesis below.[8-56] Below is the summary of their findings. Relevancy was determined purely based on if the articles answered any one of the following: (1) implant removal rate, (2) common bacterial organisms found following infection, (3) time of onset, and (4) ratio of superficial to deep infection. Furthermore, only prospective or retrospective studies were included.

Implant Removal/Retention Rate

In a study by Maruo et al,[16] 154 of 197 (78%) of SSIs were eradicated within 90 days, of which 76% were also able to retain the implants. Forty-three of 197 (22%), which were not managed within 90 days, were considered failure in management of SSI.[16] However, 93% of these 78% aforementioned were superficial infections.[16] A few studies had close to 0% to 10% implant removal.[17-20] Yin et al[21,22] in their 2010-2014 series were able to retain implant in 40 of 41 cases of late onset SSI. In contrast, many other studies required implant removal on all or majority of cases, for example, 13 of 13, 26 of 26, 20 of 20, 10 of 10 (100%), and so on.[23-27] Di Silvestre et al,[28] in a long-interval SSI detection period (3 years), found the need for 100% removal of implants in all 15 SSI cases among the 540 cases operated upon. Nevertheless, other authors such as Kanayama et al,[29] even at short-interval SSI detection period, observed 8 of 8 (100%) in need of hardware removal. Another study looking at a specific bacterial species reported 31 of 68 (46%) had need for complete removal of implant, and additional 13 of 68 (19%) has partial implant removal.[30] Among few studies with significant yet not majority implant removal proportion, one identified 61 of 84 cases (73%) had implant retention with deep SSI, and 48 of 48 (100%) with superficial SSI.[31] Similarly, other cohorts showed at least 21 of 83 (25%), 26 of 44 (58%), 22 of 42 (52%) needing implant removal.[32-34]

Bacterial Genus/Species

The common type of bacterial infection was methicillin-resistant Staphylococcus aureus (MRSA): 10 of 14 (71%), 11 of 18 (61%), 7 of 20 (35%), 5 of 10 (50%); methicillin-resistant Staphylococcus epidermidis (MRSE): 9 of 21 (43%); coagulase-negative staphylococci (possibly Staphylococcus epidermidis): 12 of 27 (45%), 3 of 9 (33%); Staphylococcus aureus: 31 of 51 (61%), 7 of 17 (41%), 6 of 20 (30%), 3 of 10 (30%); polymicrobial: 7 of 17 (41%); methicillin-resistant coagulase-negative staphylococci (MRCNS): 1 of 10 (10%); Aspergillus fumigatus (a. fumigatus): 1 of 10 (10%); gram negative, anaerobic such as Propionibacterium acnes, antibiotic-resistant strains: 5 of 9 (83%).[17,18,20,23-24,29,35-38]

SSI Onset Time

Studies that specified the onset interval of SSI, early onset (<30 days) constituted 162 of 225 (72%), 7 of 14 (50%), 13 of 20 (65%), 33 of 41 (80.5% skewed proportion; because authors didn't report late onset SSI), 42 of 51 (82% skewed).[16,19,24,37,39] Delayed onset (30 days to 1 year) constituted 57 of 225 (25%), 5 of 14 (35%), 3 of 20 (15%), 8 of 41 (19.5% skewed), and 9 of 51 (17.6 skewed), whereas late onset (>1 year) constituted 6 of 225 (3%), 2 of 14 (15%), and 4 of 20 (20%).[16,19,24,37,39]

Deep Versus Superficial SSI

Another variable that existed was identification of deep versus superficial infection. Some recorded the distribution, whereas others focused on deep SSI (via exclusion of superficial SSI). Deep SSI constituted 2 of 4 (50%), 11 of 22 (50%), 22 of 29 (76%), 10 of 17 (58%), 29 of 54 (53%), 64 of 78 (82%), 53 of 104 (51%), 1409 of 2344 (60%), 12 of 27 (45%), 7 of 9 (77%), 2 of 2 (100%), 84 of 132 (64%), 69 of 79 (87%) among various studies, whereas superficial SSI constituted 2 of 4 (50%), 11 of 22 (50%), 7 of 29 (24%), 7 of 17 (42%), 24 of 54 (47%), 13 of 78 (16.7%), 41 of 104 (39%), 867 of 2344 (37%), 15 of 27 (55%), 2 of 9 (23%), 48 of 132 (36%), 10 of 79 (13%).[25,26,29,31,36,40-45]

SSI Incidence Rate

The SSI incidence rate itself varied and is presented in Table 2.
Table 2.

Prevalence of Surgical Site Infections (SSI) Among Various Studies.

SSI (%)No. of SSIsNo. of PatientsStart YearEnd YearCountryType
1.91682419972002USAPosterior spinal fusion (n = 7)360-degree fusion (n = 9)
2.92285419862001USAPosterior spinal fusion (n = 22)
463153220032005USAPosterior spinal fusion (n = 36)
9.81111220032011USAPosterior spinal fusion of cervical spine (n = 11)
5.878134720062008USAScoliosis with posterior instrumentation (n = 78)
11.14237919962010USAGrowth rod surgeries (n = 42)
3.9512720012013USAPosterior spinal fusion of cervical spine (n = 5)
3.8216576120032013USAPosterior spinal fusion (n = 184)
10.34442819802010USAScoliosis with posterior instrumentation (n = 44)
5.22955120082012USAPosterior spinal fusion of cervical spine (n = 29)
1.426177119952006USAScoliosis with posterior instrumentation (n = 26)
4.2132317419962005USAPosterior spinal fusion (n = 105)
1.917854NANAUSAPosterior spinal fusion (n = 17)
12.74031420082011USAPosterior spinal fusion (n = 40)
1.2245367320072009USAPosterior spinal fusion (n = 45)
3.4272799120052009USAPosterior spinal fusion (n = 272)
12.1541334NANAUSAScoliosis with posterior instrumentation (n = 41)
3.245140020082010USAPosterior spinal fusion (n = 45)
6.15387420062008USAScoliosis with posterior instrumentation (n = 53)
3.5176502320052009USAPosterior spinal fusion (n = 176)
1.567446420112014USAPosterior spinal fusion (n = 67)
5.6290517020032009USAPosterior spinal fusion (n = 290)
13754NANAUSAPosterior spinal fusion (n = 7)
1.99995256720052012USAPosterior spinal fusion (n = 999)
4.124097120122013USAPosterior spinal fusion (n = 40)
21679920132014USAPosterior spinal fusion (n = 16)
0.75868365820132014USAPosterior spinal fusion (n = 586)
0.2391970620082009USAPosterior spinal fusion (n = 39)
6610020132014UKPosterior spinal fusion (n = 6)
1.41178620042006TaiwanPosterior spinal fusion (n = 9)
11.65446620082011SpainPosterior spinal fusion (n = 54)
0.932345720002009KoreaPosterior spinal fusion (n = 3)Posterior lumbar interbody fusion with pedicle screws (n = 29)
0.611159719972004JapanPosterior decompression (n = 3)Posterior spinal fusion (n = 8)
6.31422320052006JapanPosterior spinal fusion (n = 11)
4.61634520052011JapanPosterior spinal fusion (n = 16)
4.41840920072013JapanPosterior spinal fusion (n = 18)
3.152166520072014JapanPosterior spinal fusion (n = 21)
2.81656420102011JapanPosterior spinal fusion (n = 16)
7.534020112012GreecePosterior spinal fusion (n = 20)
2.0414920132014FrancePosterior spinal fusion (n = 1)
9.706869820022006FranceScoliosis with posterior instrumentation (n = 58)
10.35149620072012FranceScoliosis with posterior instrumentation (n = 51)
5.21427019941998CanadaPosterior spinal fusion (n = 10)360-degree fusion (n = 4)
2.771554019932005BrazilPosterior spinal fusion (n = 15)
Prevalence of Surgical Site Infections (SSI) Among Various Studies.

Discussion

In majority of the studies, patients who presented with SSI had to be readmitted for irrigation and debridement and implant removal/replacement. However, there were also fewer studies where revision surgery for SSI was not necessary in all the patients, for example, 9 of 14 (64%) with mean hospital stay of 43 days.[39] Key steps for management included irrigation and debridement, vacuum-assisted wound closure (VAC) in 25% and more cases, and variable term antibiotics administration (both intravenous and oral).[17-20,24,28,31,36,39,44,46-53] Many authors concluded that eradication of deep SSIs was not possible without complete removal of spinal implants. In addition, repeated site debridement could not eradicate SSI either while the implants (pedicular and/or interbody constructs) were retained, and therefore removal in most or all patients was later necessary.[23,27] Furthermore, one of this study also disclosed that the average number of surgeries required for infection treatment to be 4 (range 1-16), leading up to an average cost of SSI treatment range from quarter of a million to just shy of a million dollars per patient.[27] A smaller proportion of such recovering patients still presented with residual back pain and reduced activity.[23] To reconcile differences in practices (complete versus partial removal of implants), recently Khanna et al[54] presented a thorough retrospective analysis on implant retention and its association with antibiotic administration and onset interval. They associated delayed onset or late onset SSI patient with higher risk of SSI recurrence in absence of hardware removal. Most of their cases with early or delayed SSI were able to retain implants with early aggressive debridement.[54] When comparing the type of SSI (deep vs superficial, and late vs delayed vs early onset SSI) among these studies, eradicating deep SSI with delayed and late onset infections were most difficult, with majority needing repeated debridement and drainage.[16,29] A common problem was that of late onset SSI with low virulent p. acnes. Being low virulent bacteria, it remained undetected in the early intervals leading to widespread biofilm formation on the implants, later leading to a resilient onset of SSI.[30] For instance, because of repeated detection of P acnes, 8 of 68 (11.7%) patients underwent multiple revision surgeries in one series.[31] An exception to this trend was the study by Yin et al,[21] where they retained implants in most cases with late-onset SSI (S aureus was the common organism). It should be noted that they also noticed negative culture results in seven patients with late onset SSI (hence the underlying risk of undetected growth of organism) and one with hardware loosening due to recurrence of infection.[21] Most common organism detected were MRSA, MRSE, S epidermis, S aureus, and P acnes; nonetheless there were also others like polymicrobial and gram negative cited in the studies.[17,18,20,23,24,29,35-38] Authors noted that gram negative infection was common in early infections, whereas later ones presented with S aureus, P acnes, and so on.[39] In many studies, the interval of infection onset was limited to early, that is, <30 days, <90 days, between 30 and 90 days, or <6 months for detection of SSI, or was not mentioned.[24,27,55,56] In few, the authors specifically looked at late onset infection with average occurrence about 70 months with 15 of 540 index cases (2.77%).[28] Longer term studies, extending over 6 years also concluded 56 to 80 months as average SSI detection length with total incidence of 68 P acnes cases of 698 index cases (9.7%).[30] There were higher proportion of deep SSI over superficial SSI in most studies. Higher incidence of failure in management of SSI (recurrence) were seen with iliac fixation, polymicrobial infections, P acnes infections (of which many often were delayed or late onset), and >6-level fixation.[16] As shown in Table 2, the SSI incidence rate could be argued to be a result of varied spinal surgical practices and reporting methods, including differences in prophylactic measures, quality of hospital facilities, duration of follow-up, and the country of practice at the minimum.[7,57-61] Besides physical examination, common diagnostic tools used to detect infection are imaging (computed tomography and magnetic resonance imaging), blood culture, C-reactive protein, erythrocyte sedimentation rate, white blood cell count, and other inflammatory biomarkers. Many of these methods provide high positive predictive value but relatively lower negative predictive value. Lower negative predictive value implies that there still exist possibilities of hidden contamination, which presents itself as full-blown infection at a later interval, as delayed or late onset SSI. Furthermore, unlike superficial infection (localized to the skin and subcutaneous tissue), most deep infections lack superficial presentations making their diagnosis solely presumptive. Thus, a more cautious pathway in management of late-onset SSI may be complete removal or replacement of implants in such cases. Some authors of these studies concluded that attempts made to retain implants only lead to multiple reoperations, higher costs, and patient burden.[27] Recent studies on identification of occult infection led hardware loosening, and propensity of bacterial infestation and growth on implant surfaces outside and inside the theatre provides further evidences of levels of higher uncertainty (of subsequent infection) involved in the management of SSI and its preventive measures.[62-68]

Conclusion

Based on the data presented in myriads of prospective and retrospective studies, it is perhaps prudent to replace or remove the existing implants for management of late onset deep SSI. Additionally, although a wide range of SSI incidence rates have been observed, there exists uniformity in the type of bacterial organisms being reported.
  68 in total

1.  Is hospital information system relevant to detect surgical site infection? Findings from a prospective surveillance study in posterior instrumented spinal surgery.

Authors:  J Boetto; E Chan-Seng; G Lonjon; J Pech; A Lotthé; N Lonjon
Journal:  Orthop Traumatol Surg Res       Date:  2015-10-29       Impact factor: 2.256

2.  High frequency of low-virulent microorganisms detected by sonication of pedicle screws: a potential cause for implant failure.

Authors:  Vincent Prinz; Simon Bayerl; Nora Renz; Andrej Trampuz; Marcus Czabanka; Johannes Woitzik; Peter Vajkoczy; Tobias Finger
Journal:  J Neurosurg Spine       Date:  2019-05-28

3.  Vancomycin Powder Regimen for Prevention of Surgical Site Infection in Complex Spine Surgeries.

Authors:  Michael Van Hal; Joon Lee; Dann Laudermilch; Chinedu Nwasike; James Kang
Journal:  Clin Spine Surg       Date:  2017-10       Impact factor: 1.876

4.  The difference of surgical site infection according to the methods of lumbar fusion surgery.

Authors:  Dong Ki Ahn; Hoon Seok Park; Dae Jung Choi; Tae Woo Kim; Tae Hwan Chun; Jong Hwa Yang; Dae Geun Kim
Journal:  J Spinal Disord Tech       Date:  2012-12

5.  Predicting surgical site infection after spine surgery: a validated model using a prospective surgical registry.

Authors:  Michael J Lee; Amy M Cizik; Deven Hamilton; Jens R Chapman
Journal:  Spine J       Date:  2014-01-20       Impact factor: 4.166

6.  A Paradigm Shift Toward Terminally Sterilized Devices.

Authors:  Aakash Agarwal; Adam MacMillan; Vijay Goel; Anand K Agarwal; Chris Karas
Journal:  Clin Spine Surg       Date:  2018-08       Impact factor: 1.876

7.  Preservation of spinal instrumentation after development of postoperative bacterial infections in patients undergoing spinal arthrodesis.

Authors:  Raheel Ahmed; Jeremy D W Greenlee; Vincent C Traynelis
Journal:  J Spinal Disord Tech       Date:  2012-08

8.  Surgical Site Infections in Pediatric Spine Surgery: Comparative Microbiology of Patients with Idiopathic and Nonidiopathic Etiologies of Spine Deformity.

Authors:  Matthieu Maesani; Catherine Doit; Mathie Lorrot; Christine Vitoux; Julie Hilly; Daphné Michelet; Christophe Vidal; Florence Julien-Marsollier; Brice Ilharreborde; Keyvan Mazda; Stéphane Bonacorsi; Souhayl Dahmani
Journal:  Pediatr Infect Dis J       Date:  2016-01       Impact factor: 2.129

9.  An Analysis of Implant Retention and Antibiotic Suppression in Instrumented Spine Infections: A Preliminary Data Set of 67 Patients.

Authors:  Krishn Khanna; Abhinav Janghala; David Sing; Brennan Vail; Grigoriy Arutyunyan; Bobby Tay; Vedat Deviren
Journal:  Int J Spine Surg       Date:  2018-08-31

10.  Postoperative deep surgical-site infection after instrumented spinal surgery: a multicenter study.

Authors:  Masayoshi Ishii; Motoki Iwasaki; Tetsuo Ohwada; Takenori Oda; Takashi Matsuoka; Yuichi Tamura; Kazutaka Izawa
Journal:  Global Spine J       Date:  2013-04-15
View more
  6 in total

1.  High Prevalence of Biofilms on Retrieved Implants from Aseptic Pseudarthrosis Cases.

Authors:  Aakash Agarwal; Megan Mooney; Ashish G Agarwal; Daksh Jayaswal; Gayane Saakyan; Vijay Goel; Jeffrey C Wang; Neel Anand; Steve Garfin; Vithal Shendge; Hossein Elgafy
Journal:  Spine Surg Relat Res       Date:  2020-09-23

2.  Incidence, Management and Outcome of Delayed Deep Surgical Site Infection Following Spinal Deformity Surgery: 20-Year Experience at a Single Institution.

Authors:  Muyi Wang; Liang Xu; Bo Yang; Changzhi Du; Zezhang Zhu; Bin Wang; Yong Qiu; Xu Sun
Journal:  Global Spine J       Date:  2020-12-30

3.  Postoperative Management Strategy of Surgical Site Infection following Lumbar Dynesys Dynamic Internal Fixation.

Authors:  Liehua Liu; Lei Luo; Chen Zhao; Qiang Zhou
Journal:  Pain Res Manag       Date:  2021-10-07       Impact factor: 3.037

4.  Predictive Factors for Successful Treatment of Deep Incisional Surgical Site Infections following Instrumented Spinal Surgeries: Retrospective Review of 1832 Cases.

Authors:  Masahiro Kuroiwa; Jordy Schol; Daisuke Sakai; Natsumi Horikita; Akihiko Hiyama; Hiroyuki Katoh; Yukihiro Yamamoto; Masato Sato; Masahiko Watanabe
Journal:  Diagnostics (Basel)       Date:  2022-02-21

5.  The Current Knowledge on the Pathogenesis of Tissue and Medical Device-Related Biofilm Infections.

Authors:  Enea Gino Di Domenico; Alessandra Oliva; María Guembe
Journal:  Microorganisms       Date:  2022-06-21

6.  Postoperative Spinal Implant Infections (PSII)-A Systematic Review: What Do We Know So Far and What is Critical About It?

Authors:  Daniel Karczewski; Klaus J Schnake; Georg Osterhoff; Ulrich Spiegl; Max J Scheyerer; Bernhard Ullrich; Matthias Pumberger
Journal:  Global Spine J       Date:  2021-06-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.